Search Results 991-1000 of 19992 for Hepatitis C

1. A Study to Evaluate the Safety, Tolerability and Metabolism of BIIB105 in Subjects with Amyotrophic Lateral Sclerosis - Mayo Clinic

   - Current hepatitis C infection. - Current hepatitis B infection. - History of alcohol or substance abuse ≤6 months of Screening that would limit

2. Phase II Study Evaluating Combination Chemotherapy + Radiotherapy (RT) with Avelumab in Muscle Invasive Bladder Cancer - Mayo Clinic

   History of active hepatitis C infection; NOTE: There is no requirement to screen patients for hepatitis C; Known diagnosis of any condition (i.e. post ...

3. Surgery - Doctors - Mayo Clinic

   Nonalcoholic fatty liver disease, Cirrhosis, Hepatitis C, Hepatitis B, Portal hypertension, Alcoholic hepatitis, Hepato...cellular carcinoma, Hepatic ...

4. XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia - Mayo Clinic

   positive hepatitis C antibody may be included if they have an undetectable hepatitis C viral load. 11. Known cardiopulmonary disease defined as: 1. Unstable ...

5. Valoctocogene roxaparvovec-rvox (intravenous route) - Side effects & uses - Mayo Clinic

   Liver disease (eg, hepatitis B or C, non-alcoholic fatty liver disease, chronic alcohol consumption, and non-alcoholic steatohepatitis)—Use with caution.

6. Gastroenterology and Hepatology - Doctors - Mayo Clinic

   atty liver disease, Cirrhosis, Hepatitis C, Cholangiocarcinoma, Liver cancer, Hepatocellular carcinoma, Gallbladder cancer, Chronic liver disease, Hepatic ...

7. Pembrolizumab, Lenalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplant - Mayo Clinic

   Known active hepatitis B (e.g., hepatitis B surface antigen [HBsAg] reactive) or hepatitis C (e.g., hepatitis C virus [HCV] ribonucleic acid [RNA] [qualitative] ...

8. Mayo Clinic Transplant Center - Doctors

   , Hepatitis C, Wilson's disease, Hepatitis B, Hepatocellular carcinoma, Primary biliary cholangitis, Nonalcoholic fatty liver disease, Cirrhosis, Autoimmune ...

9. Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML Patients - Mayo Clinic

   ... C or grade ≥ 2 of neurological toxicity. Seropositive for HIV antibodies (HIV1 and HIV2), Hepatitis C antibody (Hep C Ab) or a Hepatitis B carrier ...

10. A Platform Study In Non-Small Cell Lung Cancer (NSCLC) - Mayo Clinic

    * Has either a known history of Hepatitis B virus (HBV) or has active Hepatitis C virus (HCV). * Has a history of (non-infectious) pneumonitis that required ...